{"entity":{"id":"anna-sapino","kind":"person","name":"Anna Sapino","aka":[],"tldr":"Pathologist and Scientific Director of the Candiolo Cancer Institute (INOC), Piedmont's oncology IRCCS and an OECI-certified Comprehensive Cancer Centre.","summary":"Anna Sapino is Scientific Director of the Istituto Nazionale Oncologico Candiolo (Istituto di Candiolo IRCCS), the only oncological IRCCS in Piedmont. She is a professor of anatomic pathology at the University of Turin with a long research record in breast cancer pathology and biomarkers. She oversees the institute's research programmes and its clinical research and innovation division.","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://inoc.it/it/direzione-scientifica/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Sapino+A%5BAuthor%5D"}],"tags":["leadership","clinician-scientist","pathology","breast cancer"],"related":[],"cancers":["breast-hr-positive","breast-her2-positive"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["candiolo"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["seminars-in-cancer-biology"],"dependsOn":[],"notes":[],"role":"Scientific Director","institutionId":"candiolo","specialisms":["Anatomic pathology","Breast cancer","Molecular pathology"],"profiles":[{"label":"Institution profile","url":"https://inoc.it/it/direzione-scientifica/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Sapino+A%5BAuthor%5D"}],"papers":[{"title":"Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond","journal":"Seminars in Cancer Biology","year":2021,"doi":"10.1016/j.semcancer.2020.02.016"},{"title":"Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases","journal":"ESMO Open","year":2017,"doi":"10.1136/esmoopen-2017-000253"},{"title":"Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies","journal":"ESMO Open","year":2022,"doi":"10.1016/j.esmoop.2022.100459"}]},"route":"/people/anna-sapino/","neighbours":{"cancer":[{"id":"breast-her2-positive","kind":"cancer","name":"HER2-positive breast cancer","route":"/cancers/breast-her2-positive/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"}],"institution":[{"id":"candiolo","kind":"institution","name":"Istituto di Candiolo IRCCS (FPO)","route":"/institutions/candiolo/"}],"journal":[{"id":"seminars-in-cancer-biology","kind":"journal","name":"Seminars in cancer biology","route":"/journals/seminars-in-cancer-biology/"}]}}